Key points are not available for this paper at this time.
Our clinical and literature analyses suggest that in patients with HCC with preserved liver function, the presence of large, solitary tumors, multinodular tumors, macrovascular invasion, or PHT are not contraindications for HR.
Zhong et al. (Mon,) studied this question.